Related references
Note: Only part of the references are listed.Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice
Yang Zhao et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Hypoxia Increases Aβ-Induced Tau Phosphorylation by Calpain and Promotes Behavioral Consequences in AD Transgenic Mice
Lianbo Gao et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis
Lisa Kaerst et al.
JOURNAL OF NEUROLOGY (2013)
MicroRNA-195 Protects Against Dementia Induced by Chronic Brain Hypoperfusion via Its Anti-Amyloidogenic Effect in Rats
Jing Ai et al.
JOURNAL OF NEUROSCIENCE (2013)
Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice
Christoph Koehler et al.
NEUROBIOLOGY OF AGING (2013)
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
Yoko Okamoto et al.
ACTA NEUROPATHOLOGICA (2012)
Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment
Fernanda Cechetti et al.
BRAIN RESEARCH BULLETIN (2012)
Cyclin-Dependent Kinases in Brain Development and Disease
Susan C. Su et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src
Xiu-Qing Yao et al.
BIOCHEMICAL JOURNAL (2011)
Chronic cerebral hypoperfusion in a mouse model of Alzheimer's disease: An additional contributing factor of cognitive impairment
Jin Soo Lee et al.
NEUROSCIENCE LETTERS (2011)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick et al.
STROKE (2011)
Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's disease
Laura K. Hamilton et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment
Xiaochuan Wang et al.
FASEB JOURNAL (2010)
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Sang-Won Min et al.
NEURON (2010)
Cyclin-dependent kinase-5 targeting for ischaemic stroke
Mark Slevin et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
NEUROSCIENCE Alzheimer's disease
Lennart Mucke
NATURE (2009)
Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1
Sarah L. Cole et al.
NEUROBIOLOGY OF AGING (2009)
Upregulation of BACE1 and β-Amyloid Protein Mediated by Chronic Cerebral Hypoperfusion Contributes to Cognitive Impairment and Pathogenesis of Alzheimer's Disease
Cai Zhiyou et al.
NEUROCHEMICAL RESEARCH (2009)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats
Yi Wen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Jian-Zhi Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases
Eszter Farkas et al.
BRAIN RESEARCH REVIEWS (2007)
Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory
Marco Angelo et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study
A Ruitenberg et al.
ANNALS OF NEUROLOGY (2005)
Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: Evidence from an ultrasonographic study
NM Akkawi et al.
JOURNAL OF NEUROLOGY (2005)
A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons
G Morfini et al.
EMBO JOURNAL (2004)
Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors
J Wang et al.
NATURE NEUROSCIENCE (2003)
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β
F Liu et al.
FEBS LETTERS (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion
SAL Bennett et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
